This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment

Authoring team

The management of sick sinus syndrome has three main components:

  • permanent pacing:
    • used in chronic symptomatic patients
    • dual-chamber pacing and single-chamber atrial pacing (in patients with sick sinus syndrome without atrioventricular block), as opposed to single-chamber ventricular pacing, are considered to be ‘physiological’ pacing modes because AV synchrony is maintained and the frequency of contractions of the atria and ventricles varies with metabolic demand, mimicking the heart’s natural rhythm
    • dual-chamber pacemakers have pacing leads in the right atrium and ventricle
      • indicated for use in the treatment of atrioventricular block in the absence of continuous atrial fibrillation, and in sick sinus syndrome with atrioventricular block

  • anti-arrhythmic drugs may be required to manage any tachyarrhythmia

  • anticoagulation:
    • thromboembolism is a common complication

Reference:

  1. NICE (February 2005).Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block
  2. Andersen, HR, et al. (1994). Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet, 344, 1523-28.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.